George Mason Scientist Addresses Congressional Forum on Women’s Health
Posted: November 16, 2005 at 1:00 am, Last Updated: November 30, -0001 at 12:00 am
George Mason professor Emanuel Petricoin III spoke Monday at a congressional briefing that explored the roles of proteomics, personalized medicine and advanced therapeutic tools in the diagnosis and treatment of women with gynecological and breast cancers.
The event was held at the Rayburn House Office Building on Capitol Hill.
Petricoin, formerly with the U.S. Food and Drug Administration, is codirector of the university’s Center for Applied Proteomics and Molecular Medicine. He is a renowned pioneer in proteomics research – the study of protein activity in cells – an emerging field of medicine that holds the promise of a new paradigm for early disease detection and personalized medical treatment.
Petricoin discussed how proteomic technologies are poised to advance screenings for gynecological cancers and provide a new opportunity for risk stratification and patient-tailored therapy.
“My research focuses on the discovery and development of diagnostic and treatment approaches that directly impact patients who are living with cancer and other diseases,” said Petricoin. “It is an honor to bring these findings before an audience that influences public policy and health care regulation.”
The event was sponsored by the Society for Women’s Health Research, the nation’s only nonprofit organization dedicated to the improvement of health for all women through research, education and advocacy; and the Diagnostics Access Coalition, which comprises patient, professional and trade associations that promote the value of advanced diagnostics to patients, the health care delivery system and society.
The program also included Alan Guttmacher, deputy director of the National Human Genome Research Institute, National Institutes of Health; Minetta Liu, assistant professor of medicine and oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Hospital; and a breast cancer survivor who discussed how her disease was diagnosed and treated based on her genetic profile.
“Raising public awareness of new findings and opportunities in women’s health through forums such as this is critically important to advance the education and advocacy of lawmakers, health care providers and consumers,” said Petricoin.